Pegapamodutide, a cutting-edge biomedical marvel, emerges as a beacon of hope in the quest to mitigate the multifaceted manifestations of type 2 diabetes. Through intricate interactions with the esteemed GLP-1 receptors, this transcendent pharmaceutical masterpiece exerts its influence, stimulating insulin secretion contingent upon glucose levels and meticulously overseeing the delicate balance of blood glucose.
CAT No: R2066
CAS No:1492924-65-8
Synonyms/Alias:Pegapamodutide;Pegapamodutide [USAN];UNII-WG4ID2U7FT;WG4ID2U7FT;LY2944876;Pegapamodutide (USAN);pegapamodutida;pegapamodutidum;CAS Registry Number;PEGAPAMODUTIDE [INN];PEGAPAMODUTIDE [WHO-DD];LY-2944876;Q27292621;1492924-65-8;
Chemical Name:(2R)-2-amino-3-[1-[3-[3-(2-methoxyethoxy)propylamino]-3-oxopropyl]-2,5-dioxopyrrolidin-3-yl]sulfanylpropanoic acid
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.